Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 14

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 14
---
 to future potential milestone and royalty payments associated with partnered commercial and

1

pre-commercialtherapeutic candidates. XRC is a Nevada corporation, with its principal offices located at 2200 Powell Street, Suite 310, Emeryville, California. Its telephone number is (510) 204-7239. The Arrangement The purpose of the Arrangement is to effect the acquisition of the Company by the Purchaser (the “ Transaction”). If all of the conditions to the completion of the Arrangement are satisfied or waived, the Arrangement will be implemented by way of a Court-approved statutory Plan of Arrangement under Chapter XVI – Division II of the QBCA. The following summarizes the steps which will occur under the Plan of Arrangement on the Effective Date, if all conditions to the completion of the Arrangement have been satisfied or waived. The following description of steps is qualified in its entirety by reference to the full text of the Plan of Arrangement attached as Annex E to this Circular and Proxy Statement: Commencing at 12:01 a.m. (Montreal time) (the “ Effective Time”) on the date that the Arrangement is completed (the “ Effective Date”), each of the events set out below will occur and be deemed to occur in the following sequence, in each case without any further authorization, act or formality of or by the Company, the Purchaser or any other person in each case, effective as at five-minute intervals starting at the Effective Time, except as indicated otherwise:

| a) | the Company shall reduce its issued share capital maintained in respect of the Common Shares by an aggregate                                                                                                                              
 amount equal to the aggregate Cash Amount payable to the Shareholders plus the Incentive Securities Cash Balance and distribute to the Shareholders an amount per Common Share equal to the sum of (i) the Cash Amount, plus (ii) (A) the 
 Incentive Securities Cash Balance divided by (B) the number of issued and outstanding Common Shares as at immediately prior to the Effective Time (the “Distribution”);                                                                   |

| b) | concurrently with step (a) above, each Option outstanding immediately prior to the Effective Time (whether                                                                                                                                               
 vested or unvested) shall, notwithstanding the terms of the Equity Incentive Plan or the Option Plan governing such Option or any award or similar agreement pursuant to which any Options were granted or awarded, as applicable, be deemed to be       
 unconditionally vested and exercisable and, without any further action by or on behalf of the holder thereof,